FDA, Nuance and EssilorLuxottica

Read here for an analysis of EssilorLuxottica's market leadership, growth potential, and future value drivers, with a BUY ...
RBC Capital upgraded EssilorLuxottica (ESLOY) to Outperform from Sector Perform with a price target of EUR 290, up from EUR 220. The firm cites ...
Recent health news includes EssilorLuxottica's new FDA-approved Nuance audio glasses, Baxter's CEO José Almeida retiring, Pfizer facing challenges with COVID-related revenue, WHO budget cuts amid U.S ...
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North ...
Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA: ESLX) to "outperform," citing strong fundamentals ...
Amid aid interruptions under President Trump's administration, various health sector entities adapt. The U.S. State Department ensures continued HIV treatment. EssilorLuxottica's Nuance glasses gain ...
ResultsConference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer,Mr PAUL DU SAILLANT, Deputy Chief Executive Officer,Mr STEFANO GRASSI, Chief Financial Officer, andMr ...
UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...